FDA Bans Medtech 510(K) Pathway's "Split Predicates"

Federal medical device regulators finalized a new rule this week that prohibits manufacturers from using so-called "split predicates" to establish that their new products are effectively the same as devices already on the market.

The rule, which is 2 years in the making, means that device makers can no longer reference separate predicate devices that have different intended uses when attempting to demonstrate "substantial equivalence." Companies must now rely on a single predicate device or devices that have the same intended purpose.

Help employers find you! Check out all the jobs and post your resume.